Anika Therapeutics
ANIKAlgoritmens signaler
- ›Starkt 3m-momentum (+66.8%)
- ›Starkt 6m-momentum (+52.4%)
- ›Pris över MA50 och MA200 (uppåttrend)
- ›Hög volatilitet (53% årlig)
- ›+93% från 52v-botten
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsAnika Therapeutics Posts Strong Q1 2026 Revenue Growth - TipRanks
24 min sedanAnika Therapeutics Posts Strong Q1 2026 Revenue Growth TipRanks
TipRanksANIKA THERAPEUTICS ($ANIK) Releases Q1 2026 Earnings - Quiver Quantitative
50 min sedanANIKA THERAPEUTICS ($ANIK) Releases Q1 2026 Earnings Quiver Quantitative
Quiver QuantitativeAnika lifts gross margin to 64% as commercial, OEM sales grow - Stock Titan
1 h sedanAnika lifts gross margin to 64% as commercial, OEM sales grow Stock Titan
Stock TitanAnika Therapeutics (NASDAQ: ANIK) details 2026 meeting, director votes and larger equity pools - Stock Titan
15 h sedanAnika Therapeutics (NASDAQ: ANIK) details 2026 meeting, director votes and larger equity pools Stock Titan
Stock TitanANIK (Anika Therapeutics Inc.) posts massive Q4 2025 EPS beat, dips 0.13% in muted investor reaction today. - Barrier to Entry - UBND thành phố Hải Phòng
6 d sedanANIK (Anika Therapeutics Inc.) posts massive Q4 2025 EPS beat, dips 0.13% in muted investor reaction today. - Barrier to Entry UBND thành phố Hải Phòng
UBND thành phố Hải PhòngANIK (Anika Therapeutics Inc.) swings to Q4 2025 profit against expected loss, shares edge higher. - Earnings Quality - Cổng thông tin điện tử tỉnh Tây Ninh
6 d sedanANIK (Anika Therapeutics Inc.) swings to Q4 2025 profit against expected loss, shares edge higher. - Earnings Quality Cổng thông tin điện tử tỉnh Tây Ninh
Cổng thông tin điện tử tỉnh Tây NinhAnika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
2026-04-03Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
GlobeNewswireAnika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
2026-02-26Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates Yahoo Finance
Yahoo FinanceINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
2025-09-13INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK PR Newswire NEW YORK, Sept. 13, 2025 NEW YORK , Sept. 13, 2025 /PRNewswire/ -- P
Anika TherapeuticsPR NewswireAnika to Participate in 2020 UBS Virtual Global Healthcare Conference
2020-05-12Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company, today announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Offi
Anika Therapeutics IncBusinesswireAnika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer
2020-04-27Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, t
Anika Therapeutics IncBusinesswireAnika to Issue First Quarter 2020 Financial Results and Business Highlights on Thursday, May 7
2020-04-23Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first quarter 2020 financial results after the close of the market on Thursday, May 7, 2020 and hold its inv
Anika Therapeutics IncBusinesswireAnika Appoints David Colleran as General Counsel
2020-03-04Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, t
Anika Therapeutics IncBusinesswireCORRECTING and REPLACING Anika to Issue Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights on Thursday, February 20
2020-02-06First paragraph, first sentence should read: Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2019 financial results after the c
Anika Therapeutics IncBusinesswireAnika to Issue Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights on Thursday, February 20
2020-02-06Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2019 financial results after the close of the market on Thursday, February 20,
Anika Therapeutics IncBusinesswire